Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Corrigendum to 'The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)' [American Heart Journal 171/1 (2016) 73-81].

Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Ross-Fernandes MB, da Silva JT, Galante AP, de Sousa Lara E, Costa RP, Soares RM, Cavalcanti AB, Moriguchi EH, Bruscato NM, Kesties J, Vivian L, Schumacher M, de Carli W, Backes LM, Reolão BR, Rodrigues MP, Baldissera DM, Tres GS, Lisbôa HR, Bem JB, Reolão JB, Deucher KL, Cantarelli M, Lucion A, Rampazzo D, Bertoni V, Torres RS, Verríssimo AO, Guterres AS, Cardos AF, Coutinho DB, Negrão MG, Alencar MF, Pinho PM, Barbosa SN, Carvalho AP, Taboada MI, Pereira SA, Heyde RV, Nagano FE, Baumgartner R, Resende FP, Tabalipa R, Zanini AC, Machado MJ, Araujo H, Teixeira ML, Souza GC, Zuchinali P, Fracasso BM, Ulliam K, Schumacher M, Pierotto M, Hilário T, Carlos DM, Cordeiro CG, Carvalho DA, Gonçalves MS, Vasconcelos VB, Bosquetti R, Pagano R, Romano ML, Jardim CA, de Abreu BN, Marcadenti A, Schmitt AR, Tavares AM, Faria CC, Silva FM, Fink JS, El Kik RM, Prates CF, Vieira CS, Adorne EF, Magedanz EH, Chieza FL, Silva IS, Teixeira JM, Trescastro EP, Pellegrini LA, Pinto JC, Telles CT, Sousa AC, Almeida AS, Costa AA, Carmo JA, Silva JT, Alves LV, Sales SO, Ramos ME, Lucas MC, Damiani M, Cardoso PC, Ramos SS, Dantas CF, Lopes AG, Cabral AM, Lucena AC, Medeiros AL, Terceiro BB, Leda NM, Baía SR, Pinheiro JM, Cassiano AN, Melo AN, Cavalcanti AK, Souza CV, Queiroz DJ, Farias HN, Souza LC, Santos LS, Lima LR, Hoffmann MS, Ribeiro ÁS, Vasconcelos DF, Dutra ES, Ito MK, Neto JA, Santos AF, Sousa RM, Dias LP, Lima MT, Modanesi VG, Teixeira AF, Estrada LC, Modanesi PV, Gomes AB, Rocha BR, Teti C, David MM, Palácio BM, Junior DG, Faria ÉH, Oliveira MC, Uehara RM, Sasso S, Moreira AS, Cadinha AC, Pinto CW, Castilhos MP, Costa M, Kovacs C, Magnoni D, Silva Q, Germini MF, da Silva RA, Monteiro AS, Santos KG, Moreira P, Amparo FC, Paiva CC, Poloni S, Russo DS, Silveira IV, Moraes MA, Boklis M, Cardoso QI, Moreira AS, Damaceno AM, Santos EM, Dias GM, Pinho CP, Cavalcanti AC, Bezerra AS, Queiroga AV, Rodrigues IG, Leal TV, Sahade V, Amaral DA, Souza DS, Araújo GA, Curvello K, Heine M, Barretto MM, Reis NA, Vasconcelos SM, Vieira DC, Costa FA, Fontes JM, Neto JG, Navarro LN, Ferreira RC, Marinho PM, Abib RT, Longo A, Bertoldi EG, Ferreira LS, Borges LR, Azevedo NA, Martins CM, Kato JT, Izar MC, Asoo MT, de Capitani MD, Machado VA, Fonzar WT, Pinto SL, Silva KC, Gratão LH, Machado SD, de Oliveira SR, Bressan J, Caldas AP, Lima HC, Hermsdorff HH, Saldanha TM, Priore SE, Feres NH, de Queiroz Neves A, Cheim LM, Silva NF, Reis SR, Penafort AM, de Queirós AP, Farias GM, de Los Santos ML, Ambrozio CL, Camejo CN, Dos Santos CP, Schirmann GS, Boemo JL, Oliveira RE, Lima SM, Bortolini VM, Matos CH, Barretta C, Specht CM, de Souza SR, Arruda CS, Rodrigues PA, Berwanger O.

Am Heart J. 2016 May;175:202-203. doi: 10.1016/j.ahj.2016.04.012. No abstract available.

PMID:
27179741
2.

The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).

Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Ross-Fernandes MB, da Silva JT, Galante AP, Lara Ede S, Costa RP, Soares RM, Cavalcanti AB, Moriguchi EH, Bruscato NM, Kesties, Vivian L, Schumacher M, de Carli W, Backes LM, Reolão BR, Rodrigues MP, Baldissera DM, Tres GS, Lisbôa HR, Bem JB, Reolão JB, Deucher KL, Cantarelli M, Lucion A, Rampazzo D, Bertoni V, Torres RS, Verríssimo AO, Guterres AS, Cardos AF, Coutinho DB, Negrão MG, Alencar MF, Pinho PM, Barbosa SN, Carvalho AP, Taboada MI, Pereira SA, Heyde RV, Nagano FE, Baumgartner R, Resende FP, Tabalipa R, Zanini AC, Machado MJ, Araujo H, Teixeira ML, Souza GC, Zuchinali P, Fracasso BM, Ulliam K, Schumacher M, Pierotto M, Hilário T, Carlos DM, Cordeiro CG, Carvalho DA, Gonçalves MS, Vasconcelos VB, Bosquetti R, Pagano R, Romano ML, Jardim CA, de Abreu BN, Marcadenti A, Schmitt AR, Tavares AM, Faria CC, Silva FM, Fink JS, El Kik RM, Prates CF, Vieira CS, Adorne EF, Magedanz EH, Chieza FL, Silva IS, Teixeira JM, Trescastro EP, Pellegrini LA, Pinto JC, Telles CT, Sousa AC, Almeida AS, Costa AA, Carmo JA, Silva JT, Alves LV, Sales SO, Ramos ME, Lucas MC, Damiani M, Cardoso PC, Ramos SS, Dantas CF, Lopes AG, Cabral AM, Lucena AC, Medeiros AL, Terceiro BB, Leda NM, Baía SR, Pinheiro JM, Cassiano AN, Melo AN, Cavalcanti AK, Souza CV, Queiroz DJ, Farias HN, Souza LC, Santos LS, Lima LR, Hoffmann MS, Ribeiro ÁS, Vasconcelos DF, Dutra ES, Ito MK, Neto JA, Santos AF, Sousa RM, Dias LP, Lima MT, Modanesi VG, Teixeira AF, Estrada LC, Modanesi PV, Gomes AB, Rocha BR, Teti C, David MM, Palácio BM, Junior DG, Faria ÉH, Oliveira MC, Uehara RM, Sasso S, Moreira AS, Cadinha AC, Pinto CW, Castilhos MP, Costa M, Kovacs C, Magnoni D, Silva Q, Germini MF, da Silva RA, Monteiro AS, dos Santos KG, Moreira P, Amparo FC, Paiva CC, Poloni S, Russo DS, Silveira IV, Moraes MA, Boklis M, Cardoso QI, Moreira AS, Damaceno AM, Santos EM, Dias GM, Pinho CP, Cavalcanti AC, Bezerra AS, Queiroga AV, Rodrigues IG, Leal TV, Sahade V, Amaral DA, Souza DS, Araújo GA, Curvello K, Heine M, Barretto MM, Reis NA, Vasconcelos SM, Vieira DC, Costa FA, Fontes JM, Neto JG, Navarro LN, Ferreira RC, Marinho PM, Abib RT, Longo A, Bertoldi EG, Ferreira LS, Borges LR, Azevedo NA, Martins CM, Kato JT, Izar MC, Asoo MT, de Capitani MD, Machado VA, Fonzar WT, Pinto SL, Silva KC, Gratão LH, Machado SD, de Oliveira SR, Bressan J, Caldas AP, Lima HC, Hermsdorff HH, Saldanha TM, Priore SE, Feres NH, Neves Ade Q, Cheim LM, Silva NF, Reis SR, Penafort AM, de Queirós AP, Farias GM, de los Santos ML, Ambrozio CL, Camejo CN, dos Santos CP, Schirmann GS, Boemo JL, Oliveira RE, Lima SM, Bortolini VM, Matos CH, Barretta C, Specht CM, de Souza SR, Arruda CS, Rodrigues PA, Berwanger O.

Am Heart J. 2016 Jan;171(1):73-81.e1-2. doi: 10.1016/j.ahj.2015.08.010. Epub 2015 Aug 15.

PMID:
26699603
3.

Use of intense pulsed light and a retinyl-based cream as a potential treatment for cellulite: a pilot study.

Fink JS, Mermelstein H, Thomas A, Trow R.

J Cosmet Dermatol. 2006 Sep;5(3):254-62.

PMID:
17177749
4.

Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses.

Yu L, Frith MC, Suzuki Y, Peterfreund RA, Gearan T, Sugano S, Schwarzschild MA, Weng Z, Fink JS, Chen JF.

Brain Res. 2004 Mar 12;1000(1-2):156-73.

PMID:
15053963
5.

Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage.

Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ.

J Neurochem. 2004 Feb;88(3):538-44.

6.

Sleep regulation in adenosine A2A receptor-deficient mice.

Urade Y, Eguchi N, Qu WM, Sakata M, Huang ZL, Chen JF, Schwarzschild MA, Fink JS, Hayaishi O.

Neurology. 2003 Dec 9;61(11 Suppl 6):S94-6. No abstract available.

PMID:
14663019
7.

Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.

Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, Chen JF, Schwarzschild MA, Fink JS, Linden J, Okusa MD.

J Clin Invest. 2003 Sep;112(6):883-91.

8.

Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.

Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA, Cronstein BN.

Arthritis Rheum. 2003 Jan;48(1):240-7.

9.

Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, Ramanathan M, Montesinos C, Jacobson M, Schwarzschild MA, Fink JS, Cronstein B.

Am J Pathol. 2002 Jun;160(6):2231-44.

10.

Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors.

Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, Cronstein BN.

Am J Pathol. 2002 Jun;160(6):2009-18.

11.

The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.

Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, Beilstein MA, Hackett E, Fink JS, Low MJ, Ongini E, Schwarzschild MA.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1970-5.

12.

A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.

Klein C, Schilling K, Saunders-Pullman RJ, Garrels J, Breakefield XO, Brin MF, deLeon D, Doheny D, Fahn S, Fink JS, Forsgren L, Friedman J, Frucht S, Harris J, Holmgren G, Kis B, Kurlan R, Kyllerman M, Lang AE, Leung J, Raymond D, Robishaw JD, Sanner G, Schwinger E, Tabamo RE, Tagliati M.

Am J Hum Genet. 2000 Nov;67(5):1314-9. Epub 2000 Oct 5.

13.

Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity.

Apasov SG, Chen JF, Smith PT, Schwarzschild MA, Fink JS, Sitkovsky MV.

Br J Pharmacol. 2000 Sep;131(1):43-50.

14.

Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results.

Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Kott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O.

Cell Transplant. 2000 Mar-Apr;9(2):273-8.

PMID:
10811399
15.

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.

Chen JF, Beilstein M, Xu YH, Turner TJ, Moratalla R, Standaert DG, Aloyo VJ, Fink JS, Schwarzschild MA.

Neuroscience. 2000;97(1):195-204.

PMID:
10771351
16.

Transplantation of embryonic porcine mesencephalic tissue in patients with PD.

Schumacher JM, Ellias SA, Palmer EP, Kott HS, Dinsmore J, Dempsey PK, Fischman AJ, Thomas C, Feldman RG, Kassissieh S, Raineri R, Manhart C, Penney D, Fink JS, Isacson O.

Neurology. 2000 Mar 14;54(5):1042-50.

PMID:
10720272
17.

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA.

J Neurosci. 1999 Nov 1;19(21):9192-200.

19.

NFAT interactions with the vasoactive intestinal peptide cytokine response element.

Symes A, Gearan T, Fink JS.

J Neurosci Res. 1998 Apr 1;52(1):93-104.

PMID:
9556032
20.

Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2.

Servidei T, Aoki Y, Lewis SE, Symes A, Fink JS, Reeves SA.

J Biol Chem. 1998 Mar 13;273(11):6233-41.

21.

Protein kinase C regulates adenosine A2a receptor mRNA expression in SH-SY5Y cells.

Peterfreund RA, Gies EK, Fink JS.

Eur J Pharmacol. 1997 Oct 1;336(1):71-80.

PMID:
9384256
22.

Transplantation in Parkinson's disease.

Fink JS.

Artif Organs. 1997 Nov;21(11):1199-202. Review.

PMID:
9384326
23.

A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.

Habecker BA, Symes AJ, Stahl N, Francis NJ, Economides A, Fink JS, Yancopoulos GD, Landis SC.

J Biol Chem. 1997 Nov 28;272(48):30421-8.

24.

The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression.

Symes A, Stahl N, Reeves SA, Farruggella T, Servidei T, Gearan T, Yancopoulos G, Fink JS.

Curr Biol. 1997 Sep 1;7(9):697-700.

25.
27.
29.

Region-specific central nervous system expression and axotomy-induced regulation in sympathetic neurons of a VIP-beta-galactosidase fusion gene in transgenic mice.

Tsuruda LM, Lamperti ED, Lewis SE, Tolentino PJ, Dikkes P, Villa-Komaroff L, Ebert KM, Fink JS.

Brain Res Mol Brain Res. 1996 Dec;42(2):181-92.

PMID:
9013773
30.

STAT proteins are activated by ciliary neurotrophic factor in cells of central nervous system origin.

Rajan P, Symes AJ, Fink JS.

J Neurosci Res. 1996 Feb 15;43(4):403-11.

PMID:
8699527
31.
32.

Characterization and expression of the human A2a adenosine receptor gene.

Peterfreund RA, MacCollin M, Gusella J, Fink JS.

J Neurochem. 1996 Jan;66(1):362-8.

PMID:
8522976
33.

Cellular localization of dopamine D2 receptor messenger RNA in the rat trigeminal ganglion.

Peterfreund RA, Kosofsky BE, Fink JS.

Anesth Analg. 1995 Dec;81(6):1181-5.

PMID:
7486101
34.

LIF-mediated activation of STAT proteins after neuronal injury in vivo.

Rajan P, Stewart CL, Fink JS.

Neuroreport. 1995 Nov 13;6(16):2240-4.

PMID:
8595211
36.

Quantitative analysis of the expression of a VIP transgene.

Tolentino PJ, Dikkes P, Tsuruda L, Ebert K, Fink JS, Villa-Komaroff L, Lamperti ED.

Brain Res Mol Brain Res. 1995 Oct;33(1):47-60.

PMID:
8774945
37.
39.

STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines.

Symes A, Lewis S, Corpus L, Rajan P, Hyman SE, Fink JS.

Mol Endocrinol. 1994 Dec;8(12):1750-63.

PMID:
7708062
40.

Leukemia inhibitory factor and ciliary neurotrophic factor increase activated Ras in a neuroblastoma cell line and in sympathetic neuron cultures.

Schwarzschild MA, Dauer WT, Lewis SE, Hamill LK, Fink JS, Hyman SE.

J Neurochem. 1994 Oct;63(4):1246-54.

PMID:
7523587
41.
42.

Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.

Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C, Trofatter J, Baenziger J, Diamond S, Markham C, Sullivan J, et al.

Mov Disord. 1994 May;9(3):305-10.

PMID:
7913737
43.

Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22.

MacCollin M, Peterfreund R, MacDonald M, Fink JS, Gusella J.

Genomics. 1994 Mar 15;20(2):332-3. No abstract available.

PMID:
8020991
44.

Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells.

Baumann H, Symes AJ, Comeau MR, Morella KK, Wang Y, Friend D, Ziegler SF, Fink JS, Gearing DP.

Mol Cell Biol. 1994 Jan;14(1):138-46.

46.

Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fink JS, Reppert SM.

Mol Pharmacol. 1993 Sep;44(3):524-32.

PMID:
8396714
47.
48.

Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line.

Symes AJ, Rao MS, Lewis SE, Landis SC, Hyman SE, Fink JS.

Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):572-6.

49.

Oncostatin M regulates VIP expression in a human neuroblastoma cell line.

Rao MS, Symes A, Malik N, Shoyab M, Fink JS, Landis SC.

Neuroreport. 1992 Oct;3(10):865-8.

PMID:
1421089
50.

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum.

Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM.

Brain Res Mol Brain Res. 1992 Jul;14(3):186-95.

PMID:
1279342

Supplemental Content

Support Center